Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Lymph node pain, Lymphadenopathy, Peripheral swelling, Vision blurred
Clinical narrative: the pain and swelling of my lymph node under my right arm is excessive and spreading into my right breast.; the pain and swelling of my lymph node under my right arm is excessive and spreading into my right breast.; the pain and swelling of my lymph node under my right arm is excessive and spreading into my right breast.; the pain and swelling of my lymph node under my right arm is excessive and spreading into my right breast.; swelling in my right ankle and at the bend in my arm; swelling in my right ankle and at the bend in my arm; having problems with my vision - very blurry; headaches; swelling up again causing the inability to sleep and get comfortable; swelling up again causing the inability to sleep and get comfortable; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 08Jan2022 (Lot number: FL3198) at the age of 57 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: IBUPROFEN. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8734, Location of injection: Arm Left), administration date: 31Mar2021, when the patient was 56 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 2, Batch/Lot No: EW0169, Location of injection: Arm Right, Vaccine Administration Time: 02:00 PM), administration date: 21Apr2021, when the patient was 56 years old, for Covid-19 immunization, reaction(s): "painful 2" red welt with a white ring around it".  The following information was reported: LYMPH NODE PAIN (non-serious), LYMPHADENOPATHY (non-serious), BREAST PAIN (non-serious), BREAST SWELLING (non-serious) all with onset 08Jan2022 01:00, outcome "not recovered" and all described as "the pain and swelling of my lymph node under my right arm is excessive and spreading into my right breast."; JOINT SWELLING (non-serious), PERIPHERAL SWELLING (non-serious) all with onset 08Jan2022 01:00, outcome "not recovered" and all described as "swelling in my right ankle and at the bend in my arm"; VISION BLURRED (non-serious) with onset 08Jan2022 01:00, outcome "not recovered", described as "having problems with my vision - very blurry"; HEADACHE (non-serious) with onset 08Jan2022 01:00, outcome "not recovered", described as "headaches"; INSOMNIA (non-serious), DISCOMFORT (non-serious) all with onset 08Jan2022 01:00, outcome "not recovered" and all described as "swelling up again causing the inability to sleep and get comfortable". Therapeutic measures were not taken as a result of lymph node pain, lymphadenopathy, breast pain, breast swelling, joint swelling, peripheral swelling, vision blurred, headache, insomnia, discomfort.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On the 2nd dose, The patient had a very painful 2" red welt with a white ring around it for a few days and sore lymph nodes under her arm. She took Benadryl and Ibuprofen, and it went away. On the booster, She started taking Benadryl right away to prevent the same effects from the 2nd dose. She didn't get the red welt, but even after almost 5 days, the pain and swelling of her lymph node under her right arm was excessive and spreading into her right breast. Also swelling in her right ankle and at the bend in her arm. She also having problems with her vision very blurry, headaches. Ibuprofen was not helping. Have tried ice packs and heating pad under her arm that helps temporarily, but keeps swelling up again causing the inability to sleep and get comfortable. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No known allergies.  No follow-up attempts are possible. No further information is expected.